Global IL-17 Biologics Research Report 2023-2030: A $4.37 Billion Market in 2022 - Advancements in Monoclonal Antibody Engineering Fuel Development of Targeted IL-17 Biologics
20 févr. 2024 10h57 HE
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By...
Global Antibody Discovery Services and Platforms Market 2020-2030: Analysis of Antibody Discovery Technologies and Services that Assist in the Development of Antibody Therapeutics
14 oct. 2020 04h39 HE
|
Research and Markets
Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Antibody Discovery Services and Platforms Market (3rd Edition) by Service Offered, by Antibody Discovery Method, by Nature of Antibody Generated and by...